Cedilla Therapeutics
For 60 years, sequence and structure has been the primary lens to understand protein function. It’s now time to look beyond and leverage the orchestration of protein function within cells. Cedilla Therapeutics is bringing a new dimension to precision oncology. We have discovered new ways to selectively inhibit oncogenic drivers with small molecules that conditionally modulate proteins in their functional state. Our conditional inhibitors are unlocking critical and elusive cancer targets including TEAD and CDK2. We are a driven and patient-focused team.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
6
11 to 50 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Cedilla Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- AD
Alan Dandrea
Co-founder · Other
EmailPhone
Showing 1 of 4 verified contacts
Top roles at Cedilla Therapeutics
4 distinct titles indexed · top 4 shown.
- 1bsc chemistry
- 1chemist
- 1co-founder
- 1manager
Sign up to unlock all 4 contacts at Cedilla Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Cedilla Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.